Dual-Use Vulnerabilities and Screening Deficits
Institutional partnership and technology transfer offices encounter significant screening deficits because existing administrative protocols prioritize commercial engagement and collaborative networking while overlooking emergent nonpathogen dual-use technological risks. Contemporary technology transfer frameworks typically position institutional offices as promotional conduits designed to maximize visibility, stakeholder trust, and collaborative engagement across multi-level innovation ecosystems ("Branding Innovation Ecosystems," 2025). However, this outward commercialization focus often operates in isolation from rigorous security oversight, thereby creating systemic institutional exposure to foreign interference and unauthorized knowledge dissemination. This governance disconnect is further compounded by a pervasive awareness deficit concerning dual-use technological applications in academic environments. Conventional institutional compliance mechanisms, such as standard export control regulations, remain narrowly calibrated to restrict physical access to tangible pathogens, leaving emerging disciplines such as synthetic biology largely unmonitored within standard partnership reviews ("The Dual-Use Education Gap," 2022). Furthermore, prevailing self-regulatory models depend almost entirely on individual researchers identifying potential security risks, yet higher education structures consistently fail to integrate formal instruction regarding nonpathogen dual-use concerns ("The Dual-Use Education Gap," 2022). Without specialized screening protocols and standardized risk-assessment vetting, university partnership personnel cannot reliably evaluate complex international research agreements. Consequently, technology transfer offices risk approving collaborative projects that compromise institutional integrity and research security. Resolving these institutional screening vulnerabilities requires universities to integrate systematic security vetting directly into technology transfer workflows, ensuring that international partnership expansion does not undermine institutional risk governance.